Michael Burgess actually said...

"The patient concerns must remain our primary focus."

"We need to reauthorize the user fees by the end of June to assure continuity at the FDA and increase predictability for America's medical innovators and job creators."

"I think we all agree that fostering innovation helps American patients and aids in creating American jobs."

"So we are expanding government in the process of doing this."